Pioneering treatments for toxic exposures

Our research and development efforts are advancing class-leading solutions for vital unmet needs in the treatment of heavy metal contamination.
Program
HOPO-101
Focus Area
Radiological Hazards
Stage
Phase 1
Program
HOPO-101
Focus Area
Lead Poisoning
Stage
Preclinical
Program
HOPO-101
Focus Area
Toxic Heavy Metals
Stage
Discovery

HOPO-101: A novel drug designed to remove harmful heavy metals from the body

HOPO-101 is a clinical-stage drug candidate being studied for its ability to selectively bind and promote the rapid clearance of a range of heavy metals from the body. It is uniquely designed to effectively remove harmful metals while largely sparing the essential metal ions that are crucial for maintaining normal, healthy function of the body.More about the science
HOPO-101 and all related products described on this site are STRICTLY INVESTIGATIONAL and have not been definitely shown to be safe OR effective in clinical trials. The statements made herein are based solely on studies carried out in animals and reflect the best good faith scientific assessment of the company and its management and scientific personnel. None of these statements have been evaluated by the FDA, and HOPO-101 is not FDA-approved for any use or indication. Additional studies are necessary before any definitive conclusions can made.